Fragment-based drug discovery is an approach that starts with a small collection of very small compounds that typically comprise >20 non-hydrogen atoms or ‘heavy’ atoms. The size of these compounds means that the number of possible fragments is considerably lower than the number of drug-like molecules typically generated from other drug discovery approaches.